Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07036835

Clinical Investigation of a Femtosecond Laser for Corneal Flap Creation

Clinical Investigation of the WaveLight® Ultraviolet Femtosecond Laser for Corneal Flap Creation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see how safe the WaveLight Ultraviolet Femtosecond Laser, Model 1026 (UV fs-Laser), is for creating corneal flaps during laser-assisted in situ keratomileusis (LASIK) surgery. This study will be conducted in Australia.

Detailed description

Subjects who qualify to participate will have both eyes treated. Each subject will be randomly assigned to 1 of 2 topical anesthetics (numbing eye drops) and each eye will be randomly assigned to either the UV fs-Laser or the WaveLight FS200 Infrared Femtosecond Laser, Model 1025 (IR fs-Laser). Subjects will attend a total of 6 scheduled study visits, including a preoperative Screening Visit (Day -45 to -1), a Surgery Visit (Day 0), and 4 postoperative visits at Day 1, Week 1, Month 1, and Month 3/exit, for a total individual duration of participation of approximately 4 months.

Conditions

Interventions

TypeNameDescription
PROCEDURELASIK SurgeryLaser assisted in situ keratomileusis (LASIK) surgery conducted for the purpose of correcting refractive error
DEVICEUV fs-LaserWaveLight Ultraviolet Femtosecond Laser used for creating a corneal flap during LASIK surgery
DEVICEIR fs-LaserWaveLight FS200 Infrared Femtosecond Laser used for creating a corneal flap during LASIK surgery
DEVICEAnesthetic 1 eye dropsTopical anesthetic used to numb the surface of the eye
DEVICEAnesthetic 2 eye dropsTopical anesthetic used to numb the surface of the eye

Timeline

Start date
2025-08-27
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2025-06-25
Last updated
2026-04-13

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT07036835. Inclusion in this directory is not an endorsement.